Two doses of a simple tuberculosis vaccination after surgery helps the immune system fight cancer cells and could greatly ...

Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 million grant to Fujirebio’s wholly-owned subsidiary, Fluxus, Inc. (Location: Sunnyvale, California), to ...

Universidad Carlos III de Madrid (UC3M) has presented three scientific research projects contributing to the fight against tuberculosis, the leading cause of death from infectious disease in the world ...

Children on higher-dose tuberculosis treatment regimens, as per 2010 World Health Organization guidelines, experience more ...

Many European countries are off track to meet official goals on HIV, TB, hepatitis, and STIs, a new report shows. View on ...

The Massachusetts Public Health Laboratory is accustomed to strong support from the CDC. Now it is learning to go it alone.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that ...

The History and Persistence of Our Deadliest Infection According to the World Health Organization, over 10 million people ...